CEO Conception Co-Founder SciFounders Co-Founder Preventive
More founders and investors debating China s rise should go and visit In June, I spent two weeks in Shanghai, Shenzhen, and Hong Kong meeting dozens of biotech founders, scientists, professors, investors, CEOs, and clinicians. I went in with a mindset that biotech in the U.S. was in serious trouble. I left thinking it didn t surpass More
At this point in my career across the biotech-related projects I ve run, I ve personally raised about $100 million. In some ways this feels like a lot, but given the scope of biotech and hard tech projects I care most about, it s really just a drop in the bucket. From these experiences though, I ve learned some More
One thing I ve been surprised about since starting SciFounders is how many of the founders we talk to are coming from academia rather than from industry. I think many industry scientists have great ideas too, and more should take the idea of starting a company more seriously. One big advantage of working in an industrial More
One thing I ve been surprised about since starting SciFounders is how many of the founders we talk to are coming from academia rather than from industry. I think many industry scientists have great ideas too, and more should take the idea of starting a company more seriously. One big advantage of working in an industrial More
One of the biggest differences between the software startup world (where I used to spend most of my time) and the science startup world is how little most scientists seem to value company equity. I think it’d be a really great thing for scientists and startups if this would culturally change. For many earlier career More
It seems amongst many scientists that the idea of starting a company is still looked down upon. Many seem to imagine companies as entities for which one must give up their principles and the possibility to pursue the most interesting work. But done right, that doesn’t need to be the case at all. A good More
Earlier this year, my teammates and I interviewed over 100 teams for the first cohort of SciFounder Fellowship, and by far the most frequent issues we noticed were problematic equity splits amongst teammates. Some teams knew that their equity splits were in less than ideal shape, but most groups did not. Most of the teams we More